NCT05165316Enrolling by invitation
European Long-acting Antipsychotics in Schizophrenia Trial-II
Source: ClinicalTrials.gov · Last updated 23 Jan 2026
Brief summary (registry, in English)
Schizophrenia is a chronic psychiatric illness with a heterogeneous disease course, varying from periods of symptomatic remission to relapse. Relative to the wealth of scientific data on the course of schizophrenia during the two years following the first psychotic episode, the outcome of schizophrenia patients over the first decade of their illness has been studied to a lesser degree. In this follow-up cohort study the aim is to investigate the long-term outcome of schizophrenia patients who participated in the previously conducted EULAST-I clinical trial, in the first decade after being diagnosed.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 400 (estimated)
- First submitted
- 7 Dec 2021
- Start date
- 31 Dec 2021
- Primary completion date
- Feb 2026
- Lead sponsor
- Rene Kahn
- Diseases
- Schizophrenia
- NCT number
- NCT05165316
What you commit to
- Study type: Observational
- Planned participants: 400
- From 31 Dec 2021 to the primary completion date, Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Capable of providing written informed consent / have a legal representative to provide written informed consent. \*
- Having been randomized to one of the four treatment arms (aripiprazole oral, aripiprazole depot, paliperidone oral, paliperidone depot) in the 2014-002765-30 EULAST-I clinical trial or having participated in the EULAST-I naturalistic cohort study.
- Unless prohibited by local law (e.g. due to incarceration).
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tel Hashomer The Sheba Medical Center Coordinator of this site? Confirm its status | Ramat Gan | Israel | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.